Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.

Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice. Mol Ther. 2015 May; 23(5):835-844.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.